Sort
51,593 grants matching “hepatitis”
CD24 Polymorphism and Acetaminophen Toxicity
$498,910Pan Zheng · University Of Michigan At Ann Arbor · RC1 · FY2010 · GM
Hepatitis B infection & hepatocellular carcinoma in Asian Americans
$498,905Henry Pollack · New York University School Of Medicine · P60 · FY2010 · MD
Molecular Mechanisms of Chemoprevention: Dithiolethiones
$498,850Thomas W Kensler · Johns Hopkins University · R01 · FY2007 · CA
Novel Interferons and small molecule enhancers of the interferon pathway
$498,840Kenan Christopher Garcia · Stanford University · U19 · FY2015 · AI
REGULATION OF ADENOVIRUS PROTEINASE BY A PEPTIDE AND DNA
$498,817Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2000 · AI
Mechanisms of luminal protein targeting in kidney and hepatic epithelial cells
$498,797Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2011 · DK
Project ECHO Extension for Community Healthcare Outcomes
$498,794Sanjeev Arora · University Of New Mexico · UC1 · FY2006 · HS
Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications
$498,792Vincent Lo Re · University Of Pennsylvania · R01 · FY2013 · HS
A Safe and Tolerable Niacin Analog for Treatment of Nonalcoholic Steatohepatitis
$498,785Claude Benedict · Arisaph Pharmaceuticals, Inc. · R43 · FY2015 · DK
Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications
$498,780Vincent Lo Re · University Of Pennsylvania · R01 · FY2010 · HS
Modeling liver metabolism with patient-specific iPS derived hepatocytes
$498,778Stephen A Duncan · Medical College Of Wisconsin · RC1 · FY2010 · DK
Regulation of drug metabolizing enzymes by miRNAs
$498,772Todd C. Skaar · Indiana University Indianapolis · R01 · FY2017 · GM
Improved Mimotope Structures and Scaffolds for Prime-Boost Strategies
$498,724David Davis · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2009 · AI
HEPADNAVIRUS INFECTIONS AND LIVER CANCER
$498,701Institute For Cancer Research · R01 · FY2002 · AI
Light Microscopy core for NIDDK
$498,613Jeffrey Reece · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2024 · DK
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$498,613Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Genetic determinants of NAFLD severity and progression
$498,594Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2015 · DK
Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs
$498,584Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · DA
Hepatitis B infection & hepatocellular carcinoma in Asian Americans
$498,517Henry Pollack · New York University School Of Medicine · P60 · FY2011 · MD
Validity of Self-Reported Adult Vaccination Status
$498,517Feifei Wei · Healthpartners Institute · U01 · FY2008 · IP
Effect of Oral Cimetidine in the Protoporphyrias (IND 153247 submitted 9/2/2020)
$498,495Amy Kathryn Dickey · Massachusetts General Hospital · R01 · FY2021 · FD
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION
$498,493Buck Institute For Age Research · R01 · FY2004 · AG
BMP inhibitors and the study of disease mechanisms in anemia of inflammation
$498,456Randall T Peterson · Massachusetts General Hospital · R01 · FY2010 · DK
Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications
$498,425Vincent Lo Re · University Of Pennsylvania · R01 · FY2014 · HS
Bariatric Surgery Clinical Research Consortium
$498,409Bruce M Wolfe · Oregon Health & Science University · U01 · FY2011 · DK